Hólyagrák: vizsgálatok itt: Chile
5 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Concepción, La Serena, Santiago, Temuco
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 1/2. fázisTaking peopleKEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
- Where
- Santiago
- Életkor
- 18 év and over
- People
- 55 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07232602 · EU 2025-522253-19-00 - 2. fázisTaking peopleA Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Where
- Antofagasta, Santiago, Valdivia, Viña del Mar
- Életkor
- 18 év and over
- People
- 308 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06833073 · EU 2024-517335-46-00 - 1/2. fázisTaking peopleA Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
- Where
- Santiago
- Életkor
- 18 év and over
- People
- 48 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05562830 · EU 2023-506384-34-00 - 2. fázisTaking peopleA Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Where
- La Serena, Providencia, Santiago
- Életkor
- 18 év and over
- People
- 372 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04879329 · EU 2022-500030-28-01